Xin Tao

TL;DR: Blastocyst biopsy with rapid quantitative real-time polymerase chain reaction-based comprehensive chromosomal screening results in statistically significantly improved IVF outcomes, as evidenced by meaningful increases in sustained implantation and delivery rates.

TL;DR: In women ≤ 42 years old, transferring a single euploid blastocyst results in ongoing pregnancy rates that are the same as transferring two untested blastocysts while dramatically reducing the risk of twins.

TL;DR: These nonselection data provide the first prospective, blinded, clinical study directly measuring the predictive value of aneuploidy screening for clinical outcome, whereas implantation and delivery rates of euploid embryos are increased relative to the entire cohort of transferred embryos.

TL;DR: A SNP microarray-based single cell aneuploidy screening technology has been established and validated and clinical validation studies are underway to determine the predictive value of this methodology.

TL;DR: These data demonstrate the first qPCR technology capable of accurate aneuploidy screening of all 24 chromosomes in 4 hours, and provide an opportunity to evaluate trophectoderm biopsies with subsequent fresh euploid blastocyst transfer.